Aplagon is also planning for 2026 a Phase 2 clinical trial for arteriovenous fistula (AVF) maturation failure in Europe, following the successful completion of its Phase 1 AVF trial. The study ...

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...

Treatment is determined by the type of stroke suffered (i.e., ischemic or hemorrhagic) rather than the anatomic location. Symptoms referable to the anterior circulation — specifically, anterior and ...

Ischemic colitis and mesenteric ischemia are both types of bowel ischemia. Ischemic colitis refers to reduced blood flow to the large intestine, while mesenteric ischemia happens due to reduced blood ...

Mesenteric ischemia, or small bowel ischemia, involves a blockage of blood flow to the small intestine. Symptoms include pain and bloating. It often results from blood clots or atherosclerosis.

Please provide your email address to receive an email when new articles are posted on . PARK CITY, Utah — Outcomes from the phase 1/2a HORNBILL study indicate a potential disease-modifying effect of ...

For stable patients with chronic total occlusion (CTOs), treatment with an invasive strategy that includes coronary revascularization does not reduce the risk of cardiovascular death or myocardial ...

The growth of the acute ischemic stroke market is expected to be driven primarily by increased awareness of symptoms, advances in acute stroke care, and a robust pipeline of potential candidates such ...

Time is of the essence in establishing the diagnosis of stroke and determining whether the patient is a candidate for thrombolytic therapy, ideally initiated within the “golden hour” after arrival at ...